Lipid-coated mesoporous silica nanoparticles for anti-viral applications via delivery of CRISPR-Cas9 ribonucleoproteins. - LaBauve AE; Saada EA; Jones IKA; Mosesso R; Noureddine A; Techel J; Gomez A; Collette N; Sherman MB; Serda RE; Butler KS; Brinker CJ; et al. (Scientific reports, 2023)